Drug Saf
-
Publication Venue For
- Authors' Reply to Courtney Suggs and Colleagues' Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs".. 41:1423-1424. 2018
- A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials.. 41:807-816. 2018
- A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials.. 41:465-471. 2018
- Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs.. 41:363-376. 2018
- Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease.. 39:715-727. 2016
- Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.. 39:755-762. 2016
- Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary intervention.. 38:481-491. 2015
- Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.. 37:19-31. 2014
- A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization: a retrospective study in agitated hospitalized patients.. 35:725-731. 2012
- Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.. 35:547-553. 2012
- The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.. 35:233-244. 2012
- Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.. 33:503-522. 2010